Effective August 3, 2023, Malcolm G. Witter resigned as a director of Navidea Biopharmaceuticals, Inc. (the ?Company?) and as a member of the Audit Committee and Compensation, Nominating and Governance Committee of the Board. Mr. Witter?s resignation did not result from any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0381 USD | +1.33% | +8.86% | -30.98% |
1st Jan change | Capi. | |
---|---|---|
-30.98% | 3.81M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NAVB Stock
- News Navidea Biopharmaceuticals, Inc.
- Navidea Biopharmaceuticals, Inc. Announces Resignation of Malcolm G. Witter as Director, Member of the Audit Committee and Compensation, Nominating and Governance Committee of the Board